GAIN THERAPEUTICS, INC Operating Lease, Liability, Noncurrent
GAIN THERAPEUTICS, INC (GANX) had Operating Lease, Liability, Noncurrent of $156.76 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Noncurrent $156.76K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $182.13K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $211.24K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $65.03K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $156.76K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $182.13K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $211.24K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $65.03K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $92.85K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $30.59K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $53.60K 10-K · filed 2026-03-26 |
| 2024-09-30 | $96.22K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $134.32K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $177.37K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $229.85K 10-K · filed 2025-03-27 |
| 2023-09-30 | $263.46K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $330.07K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $385.92K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $441.78K 10-K · filed 2024-03-26 |
| 2022-09-30 | $468.76K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $544.76K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $625.45K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $695.05K 10-K · filed 2023-03-23 |
| 2021-09-30 | $576.46K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $630.90K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $377.60K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $400.32K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |